Homeobox gene expression and mutation in cervical carcinoma cells

Cancer Science

Volumn 94, Issue 5, 2003, Pages 437-441

  Hung, Yao Ching ^a   Ueda, Masatsugu ^b   Terai, Yoshito ^b   Kumagai, Koji ^b   Ueki, Ken ^b   Kanda, Koji ^b   Yamaguchi, Hiroyuki ^b   Akise, Daisuke ^b   Ueki, Minoru ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HOMEODOMAIN PROTEIN; MESSENGER RNA; PRIMER RNA;

ARTICLE; CANCER CELL; CELL LINE; CONTROLLED STUDY; EXON; FEMALE; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; HOMEOBOX; HOX GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MALIGNANT TRANSFORMATION; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; UTERINE CERVIX CARCINOMA;

EID: 0037743898     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2003.tb01461.x     Document Type: Article

References (35)

1. McGinnis W, Krumlauf R. Homeobox genes and axial patterning. Cell 1992; 68: 283-302.
2. Scott MP, Tamkun JW, Hartzell GW. The structure and function of the homeodomain. Biochim Biophys Acta 1989; 989: 25-48.
3. Scott MP. Vertebrate homeobox gene nomenclature. Cell 1992; 71: 551-3.
4. Hatano M, Roberts CW, Minden M, Crist WM, Korsmeyer SJ. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science 1991; 253: 79-82.
5. Kamps MP, Murre C, Sun XH, Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 1990; 60: 547-55.
6. Blatt C, Aberdam D, Schwartz R, Sachs L. DNA rearrangement of a homeobox gene in myeloid leukaemic cells. EMBO J 1988; 7: 4283-90.
7. Cillo C, Barba P, Freschi G, Bucciarelli G, Magli MC, Boncinelli E. HOX gene expression in normal and neoplastic human kidney. Int J Cancer 1992; 51: 892-7.
8. De Vita G, Barba P, Odartchenko N, Givel JC, Freschi G, Bucciarelli G, Magli MC, Boncinelli E, Cillo C. Expression of homeobox-containing genes in primary and metastatic colorectal cancer. Eur J Cancer 1993; 29A: 887-93.
9. Calvo R, West J, Franklin W, Erickson P, Bemis L, Li E, Helfrich B, Bunn P, Roche J, Brambilla E, Rosell R, Gemmill RM, Drabkin HA. Altered Hox and Wnt7a expression in human lung cancer. Proc Natl Acad Sci USA 2000; 97: 12776-81.
10. Alami Y, Castronovo V, Belotti D, Flagiello D, Clausse N. HOXC5 and HOXC8 expression are selectively turned on in human cervical cancer cells compared to normal keratinocytes. Biochem Biophys Res Commun 1999; 257: 738-45.
11. Li H, Huang CJ, Choo KB. Expression of homeobox genes in cervical cancer. Gynecol Oncol 2002; 84: 216-21.
12. Kolon TF, Wiener JS, Lewitton M, Roth DR, Gonzales ET, Lamb DJ. Analysis of homeobox gene HOXA10 mutations in cryptorchidism. J Urol 1999; 161: 275-80.
13. Thompson AA, Nguyen LT. A megakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation. Nat Genet 2000; 26: 397-8.
14. Mortlock DP, Innis JW. Mutation of HOXA13 in hand-foot-genital syndrome. Nat Genet 1997; 15: 179-80.
15. Muragaki Y, Mundlos S, Upton J, Olsen BR. Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science 1996; 272: 548-51.
16. Goodman FR, Scambler PJ. Human HOX gene mutations. Clin Genet 2001; 59: 1-11.
17. Ueda M, Ueki M, Yamada T, Okamoto Y, Maeda T, Sugimoto O, Otsuki Y. Scatchard analysis of EGF receptor and effects of EGF on growth and TA-4 production of newly established uterine cervical cancer cell line (OMC-1). Hum Cell 1989; 2: 401-10.
18. Ueda M, Ueki M, Sugimoto O. Characterization of epidermal growth factor (EGF) receptor and biological effect of EGF on human uterine cervical adenocarcinoma cell line OMC-4. Hum Cell 1993; 6: 218-25.
19. Taguchi S. Establishment and characterization of the human uterine cervical epidermoid cancer cell line. Acta Obstet Gynaecol Jpn 1981; 33: 1180-8.
20. Ishiwata I, Nozawa S, Kiguchi K, Kurihara S, Okumura H. Establishment of human uterine cervical cancer cell line and comparative studies between normal and malignant uterine cervical cells in vitro. Acta Obstet Gynaecol Jpn 1978; 30: 731-8.
21. Nozawa S, Udagawa Y, Ohta H, Kurihara S, Fishman WH. Newly established uterine cervical cancer cell line (SKG-III) with Regan isoenzyme, human chorionic gonadotropin β-subunit, and pregnancy-specific β1-glycoprotein phenotypes. Cancer Res 1983; 43: 1748-60.
22. Mitsuhashi A, Tanaka H, Tanaka N, Sugita M, Shirasawa H, Tokita H, Eda H. Establishment and characterization of a new HPV-negative squamous cell carcinoma cell line (Yumoto) from the human uterine cervix. Gynecol Oncol 1998; 70: 339-47.
23. Shirasawa H, Tomita Y, Fuse A, Yamamoto T, Tanzawa H, Sekiya S, Takamizawa H, Simizu B. Structure and expression of an integrated human papillomavirus type 16 genome amplified in a cervical carcinoma cell line. J Gen Virol 1989; 70: 1913-9.
24. Suzumori K, Yasui Y. NUZ-1. Hum Cell 1988; 1: 454.
25. Ishiwata I, Ishiwata C, Soma M, Ono I, Nakaguchi T, Nozawa S, Ishikawa H. Differences between cell lines of uterine cervical glassy cell carcinoma and large cell nonkeratinizing squamous cell carcinoma. Anal Quant Cytol Histol 1990; 12: 290-8.
26. Koizumi M, Uede T, Shijubo N, Kudo R, Hashimoto M, Kikuchi K. New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential. Cancer Res 1988; 48: 6565-72.
27. Ueda M, Terai Y, Kumagai K, Ueki K, Kanemura M, Ueki M. Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells. Int J Cancer 2001; 91: 778-82.
28. Ueda M, Terai Y, Yamashita Y, Kumagai K, Ueki K, Yamaguchi H, Akise D, Hung YC, Ueki M. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas. Int J Cancer 2002; 98: 335-43.
29. Ueda M, Yamashita Y, Takehara M, Terai Y, Kumagai K, Ueki K, Kanda K, Yamaguchi H, Akise D, Hung YC, Ueki M. Survivin gene expression in endometriosis. J Clin Endocrinol Metab 2002; 87: 3452-9.
30. Kosaki K, Kosaki R, Suzuki T, Yoshihashi H, Takahashi T, Sasaki K, Tomita M, McGinnis W, Matsuo N. Complete mutation analysis panel of the 39 human HOX genes. Teratology 2002; 65: 50-62.
31. Ueda M, Gemmill RM, West J, Winn R, Sugita M, Tanaka N, Ueki M, Drabkin HA. Mutations of the β- and γ-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 2001; 85: 64-8.
32. Wewer UM, Mercurio AM, Chung SY, Albrechtsen R. Deoxyribonucleic-binding homeobox proteins are augmented in human cancer. Lab Invest 1990; 63: 447-54.
33. Shim C, Zhang W, Rhee CH, Lee JH. Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. Clin Cancer Res 1998; 4: 3045-50.
34. Cillo C, Faiella A, Cantile M, Boncinelli E. Homeobox genes and cancer. Exp Cell Res 1999; 248: 1-9.
35. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J, Sukumar S. Compromised HOXA5 function can limit p53 expression in human breast tumors. Nature 2000; 405: 974-8.